Quality of amoxicillin formulations in some Arab countries

Journal of Clinical Pharmacy and Therapeutics

Volumn 33, Issue 4, 2008, Pages 375-379

  Kyriacos, S ^a   Mroueh, M ^a   Chahine, R P ^a   Khouzam, O ^a  

^a LEBANESE AMERICAN UNIVERSITY   (Lebanon)

Author keywords

Amoxicillin; Antimicrobial drug; Drug quality; Essential drugs

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT;

ARTICLE; DRUG CAPSULE; DRUG DETERMINATION; DRUG FORMULATION; DRUG LABELING; DRUG QUALITY; EGYPT; JORDAN; LEBANON; SAUDI ARABIA; DRUG STABILITY; DRUG STORAGE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MEDICAL LITERATURE; MICROCAPSULE; QUALITY CONTROL; STANDARD; SUSPENSION;

AMOXICILLIN; ANTI-BACTERIAL AGENTS; CAPSULES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG LABELING; DRUG STABILITY; DRUG STORAGE; EGYPT; JORDAN; LEBANON; PHARMACOPOEIAS AS TOPIC; QUALITY CONTROL; SAUDI ARABIA; SUSPENSIONS;

EID: 49849097768     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2008.00926.x     Document Type: Article

References (15)

1. WHO (1999) Counterfeit drugs: guidelines for the development of measures to combat counterfeit drugs, Department of Essential Drugs and Other Medicines. Geneva: WHO.
2. WHO (1999) Summary of WHO counterfeit drug database as of April 1999, unpublished paper of the WHO Division of Drug Management and Policies. Geneva: WHO.
3. Taylor RB, Shakoor O, Behrens RH et al. (2001) Pharmacopoeial quality of drugs supplied by Nigerian pharmacies. Lancet, 357, 1933-1936.
4. Kapp C (2002) Counterfeit drug problem "underestimated". Lancet, 360, 1080.
5. Shakoor O, Taylor RB, Behrens RH (1997) Assessment of the incidence of substandard drugs in developing countries. Tropical Medicine and International Health, 2, 839-845.
6. Verduin-Muttiganzi R, Verduin-Muttiganzi G (1997) Letter to the editors. Tropical Medicine and International Health, 3, 602-603.
7. WHO (2002) Essential medicines. WHO Model List, 12th edn (revised April 2002). Geneva: WHO.
8. US Pharmacopoeia (2005) USP 28 /NF 23. The United States Pharmacopeial Convention, Inc., Rockville, MD, USA.
9. Andriollo O, Machuron L, Videau JY et al. (1997) Approvsionnement pour l'aide humanitaire ou les pays en developpement: la qualite du medicament essentiel multisources. S.T.P. Pharma Pratiques, 7, 412-429. (French).
10. WHO (1992) Counterfeit drugs - Report of a WHO/ IFPMA Workshop, 1992. WHO/DMP/CFD / 92. Geneva: WHO.
11. WHO (1998) Report of the International Workshop on Counterfeit Drugs. WHO/DRS /CFD / 98.1. Geneva: WHO.
12. Wondemagegnehu E (1995) Conterfeit and substandard drugs in Myanmar and Vietnam. Geneva: WHO.
13. Afu S (1999) Incidence of substandard drugs in developing countries. Tropical Medicine and International health, 4, 72-73.
14. Wan Po AL (2001) Too much, too little or none at all: dealing with substandard and fake drugs. Lancet, 357, 1904.
15. Issack MI (2001) Substandard drugs. Lancet, 358, 1463.